Under construction – not a live service
Sign in
Taking people in GeorgiaNo phase

Studies ways to expand opioid treatment in prisons and probation

Studies ways to offer opioid treatment to adults who inject drugs.

Key facts

Who runs it
Yale University
Where
Tbilisi, GeorgiaSee the siteAlso in 4 other countries, 4 sites
Trial code
Registry title
PRIDE III Prison Interventions and HIV Prevention Collaboration
Status
Recruiting
People taking part
300 people, planned
Started
5 Nov 2024
Expected to end
Dec 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Opioid Agonist Therapy
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults in prison or probation systems who inject opioids, and for prison and probation staff and OAT providers who work with them.

Age
18 years or older
Sex
All sexes can join.

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Aim 1:
  • Quantitative surveys for prison OAT providers; Being 18 years or older; Being currently assigned and working as a probation OAT provider for a probation site
  • ECHO procedures; Aim 2:
  • Quantitative surveys for people in probation; Being 18 years or older; Screen yes to opioid injection on the online screener questionnaire; Currently in probation
  • Quantitative surveys for probation and prison officers; Being 18 years or older; Being currently assigned and working as a probation or prison officer at a probation site
  • Focus Groups (People in probation); Being 18 years or older; Screen yes to opioid injection criteria on the online screener; Currently in probation
  • Focus Groups (Probation and prison officers); Being 18 years or older; Being currently assigned and working as a probation or prison officer at a probation; Has more than 3 months of field experience; Works at a probation site within 25 kilometers of an OAT site

Who cannot take part

  • -

Where in Georgia

Also in 4 other countries, 4 sites

  • Alternative GeorgiaTbilisi, GeorgiaContact: David Oliveros, MPHTaking people

About the trial

What the trial wants to find out

The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).

The 2 groups in the trial

  • Aim 1- ImplementationTreatment being tested

    Scale-up Opioid Agonist Therapy (OAT) as HIV prevention in prisons and pre-trial detention centers in EECA for individuals with Opioid Use Disorder (OUD) and link them to community treatment after release using development of NIATx learning collaboratives with prison OAT providers (addiction care specialists or primary care doctors). OAT scale-up data will be collected from each country's national OAT database, as well as administration of survey to prison narcologists.

    Treatment: Opioid Agonist Therapy

  • Aim 2- Scale-UpTreatment being tested

    Scale-up OAT as HIV prevention in the newly formed probation system in EECA for individuals with OUD and link them to OAT treatment as part of routine care to align public safety and public health using development of NIATx learning collaboratives with probation and prison officers in Kyrgyzstan, Tajikistan, Moldova, and Georgia. OAT scale-up data will be collected from each member country's national OAT database, and administer a survey to probation officers.

    Treatment: Opioid Agonist Therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
PRIDE III Prison Interventions and HIV Prevention Collaboration
Plain-language title
Studies ways to expand opioid treatment in prisons and probationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
10 September 2026